eplex RP Controls
Respiratory symptoms can be caused by a wide range of infections. While testing helps determine the exact cause, quality controls are essential to ensure accurate results. MMQCI’s eplex RP Control M306 and eplex RP Negative monitor the detection of all the pathogens on the cobas® eplex RP panel.
eplex BCID-FP Controls
Fungemia such as candidemia are serious, often life-threatening infections, where early detection and appropriate therapy are critical to reduce mortality. MMQCI’s eplex BCID-FP Control M320v1.1 and eplex BCID-FP Negative help to reliably identify potential pathogenic fungal organisms in positive blood culture to ensure correct diagnosis.
eplex BCID-GP Controls
Our eplex BCID-GP Control M323v1.1 and eplex BCID-GP Negative monitor the qualitative detection of gram-positive pathogens and resistance genes to help with the diagnosis and treatments of severe bacterial infections such as Staph infections that can lead to critical conditions such as sepsis.
eplex BCID-GN Control
E.coli and other blood culture gram-negative bacteria can cause severe systemic infections. Our eplex BCID-GN Control M326 and eplex BCID-GN Negative can facilitate the correct identification of gram-negative bacteria and resistance markers, to help guide clinicians to determine timely and effective antibiotic therapy.
eplex RP2 Control
Our eplex RP2 Control M451 can help ensure the correct identification of more than 20 of the most common viral and bacterial organisms associated with upper respiratory infection, including SARS-CoV-2, the virus that causes COVID-19, allowing clinicians to make informed patient care decisions faster.